Skip to main navigation Skip to search Skip to main content

Determination of a potential antitumor quassinoid in rat plasma by UPLC-MS/MS and its application in a pharmacokinetic study

  • Qiang Zhang
  • , Yonghui Yuan
  • , Jianchun Cui
  • , Tingting Xiao
  • , Zhipeng Deng*
  • , Daqing Jiang*
  • *Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

12 Citations (Scopus)

Abstract

A sensitive UPLC-MS/MS method was developed and validated for the determination of brusatol in rat plasma. Chromatographic separation was carried out on a C18 column using methanol and 10 mM ammonium acetate containing 0.1% (v/v) formic acid (55:45, v/v). The lower limit of quantification (LLOQ) was 1.0 ng/mL for brusatol in plasma. The intra- and inter-day precision for the analyte ranged from 3.2% to 9.2% and 1.3% to 7.8%, and the accuracy was between 97.3% and 108.5%. The method was successfully applied in a pharmacokinetic study of brusatol following intravenous injection (0.5, 1.0, and 2.0 mg/kg) of brusatol.

Original languageEnglish
Pages (from-to)143-148
Number of pages6
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume124
DOIs
Publication statusPublished - 30 May 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 9 - Industry, Innovation, and Infrastructure
    SDG 9 Industry, Innovation, and Infrastructure

User-Defined Keywords

  • Brusatol
  • Pharmacokinetic study
  • Quassinoid
  • Rat plasma
  • UPLC-MS/MS

Fingerprint

Dive into the research topics of 'Determination of a potential antitumor quassinoid in rat plasma by UPLC-MS/MS and its application in a pharmacokinetic study'. Together they form a unique fingerprint.

Cite this